← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2023-12-31 · Filed 2024-02-14 · Accession 0001420506-24-000478
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | ADAPTIVE BIOTECHNOLOGIES COR | COM · 00650F109 | LONG | 1,357,490 | $6.7 million |
| 2 | ALECTOR INC | COM · 014442107 | LONG | 3,324,308 | $26.5 million |
| 3 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 146,313 | $40.1 million |
| 4 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 26,750,000 | $28.4 million |
| 5 | AMGEN INC | COM · 031162100 | LONG | 58,200 | $16.8 million |
| 6 | APOGEE THERAPEUTICS INC | COM · 03770N101 | LONG | 681,101 | $19.0 million |
| 7 | ARGENX SE | SPONSORED ADR · 04016X101 | LONG | 153,204 | $58.3 million |
| 8 | ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 · 04351PAD3 | LONG | 126,897,000 | $130.4 million |
| 9 | BIOCRYST PHARMACEUTICALS INC | COM · 09058V103 | LONG | 5,718,477 | $34.3 million |
| 10 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 114,338,000 | $138.4 million |
| 11 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 67,294,000 | $57.3 million |
| 12 | COMPASS THERAPEUTICS INC | COM · 20454B104 | LONG | 317,761 | $495,707 |
| 13 | CULLINAN THERAPEUTICS INC | COM · 230031106 | LONG | 1,240,865 | $12.6 million |
| 14 | CUTERA INC | NOTE 2.250% 6/0 · 232109AD0 | LONG | 31,900,000 | $8.4 million |
| 15 | CUTERA INC | NOTE 4.000% 6/0 · 232109AG3 | LONG | 29,000,000 | $6.5 million |
| 16 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 4,215,573 | $61.5 million |
| 17 | DBV TECHNOLOGIES S A | SPONSORED ADR · 23306J101 | LONG | 7,843,285 | $7.5 million |
| 18 | DECIPHERA PHARMACEUTICALS IN | COM · 24344T101 | LONG | 1,169,490 | $18.9 million |
| 19 | DENALI THERAPEUTICS INC | COM · 24823R105 | LONG | 461,769 | $9.9 million |
| 20 | DEXCOM INC | NOTE 0.250%11/1 · 252131AK3 | LONG | 45,000,000 | $47.2 million |
| 21 | DYNE THERAPEUTICS INC | COM · 26818M108 | LONG | 755,811 | $10.1 million |
| 22 | EXACT SCIENCES CORP | NOTE 0.375% 3/0 · 30063PAC9 | LONG | 131,000,000 | $123.1 million |
| 23 | GLAUKOS CORP | COM · 377322102 | LONG | 242,760 | $19.3 million |
| 24 | GUARDANT HEALTH INC | COM · 40131M109 | LONG | 758,928 | $20.5 million |
| 25 | GUARDANT HEALTH INC | NOTE 11/1 · 40131MAB5 | LONG | 268,252,000 | $189.1 million |
| 26 | HARROW INC | COM · 415858109 | LONG | 1,498,584 | $16.8 million |
| 27 | HILLEVAX INC | COM · 43157M102 | LONG | 203,407 | $3.3 million |
| 28 | IMMUNOCORE HLDGS PLC | ADS · 45258D105 | LONG | 611,365 | $41.8 million |
| 29 | INSMED INC | NOTE 1.750% 1/1 · 457669AA7 | LONG | 52,388,000 | $56.1 million |
| 30 | INSPIRE MED SYS INC | COM · 457730109 | LONG | 184,658 | $37.6 million |
| 31 | INSULET CORP | NOTE 0.375% 9/0 · 45784PAK7 | LONG | 63,000,000 | $72.7 million |
| 32 | INVITAE CORP | NOTE 2.000% 9/0 · 46185LAB9 | LONG | 16,781,000 | $14.9 million |
| 33 | IONIS PHARMACEUTICALS INC | NOTE 4/0 · 462222AD2 | LONG | 5,240,000 | $5.5 million |
| 34 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 568,157 | $60.8 million |
| 35 | IRONWOOD PHARMACEUTICALS INC | NOTE 0.750% 6/1 · 46333XAF5 | LONG | 37,509,000 | $39.5 million |
| 36 | IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 · 46333XAH1 | LONG | 15,500,000 | $16.9 million |
| 37 | KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 · 48576UAA4 | LONG | 65,976,000 | $33.0 million |
| 38 | KEROS THERAPEUTICS INC | COM · 492327101 | LONG | 1,118,961 | $44.5 million |
| 39 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 196,200 | $24.3 million |
| 40 | LANTHEUS HLDGS INC | COM · 516544103 | LONG | 495,100 | $30.7 million |
| 41 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 562,600 | $33.9 million |
| 42 | MARAVAI LIFESCIENCES HLDGS I | COM CL A · 56600D107 | LONG | 5,040,635 | $33.0 million |
| 43 | MERUS N V | COM · N5749R100 | LONG | 370,679 | $10.2 million |
| 44 | MINERALYS THERAPEUTICS INC | COM · 603170101 | LONG | 2,023,900 | $17.4 million |
| 45 | NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 · 63009RAD1 | LONG | 3,650,000 | $2.7 million |
| 46 | NEOGENOMICS INC | NOTE 1.250% 5/0 · 64049MAA8 | LONG | 10,000,000 | $9.4 million |
| 47 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 65,601,000 | $50.2 million |
| 48 | NEUROCRINE BIOSCIENCES INC | COM · 64125C109 | LONG | 715,209 | $94.2 million |
| 49 | NEVRO CORP | COM · 64157F103 | LONG | 1,776,368 | $38.2 million |
| 50 | NOVOCURE LTD | NOTE 11/0 · 67011XAB9 | LONG | 135,834,000 | $117.9 million |
| 51 | NUVASIVE INC | NOTE 0.375% 3/1 · 670704AJ4 | LONG | 80,530,000 | $74.3 million |
| 52 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 1,107,770 | $36.0 million |
| 53 | OUTSET MED INC | COM · 690145107 | LONG | 2,400,427 | $13.0 million |
| 54 | PARAGON 28 INC | COM · 69913P105 | LONG | 3,361,824 | $41.8 million |
| 55 | PENUMBRA INC | COM · 70975L107 | LONG | 222,792 | $56.0 million |
| 56 | PULMONX CORP | COM · 745848101 | LONG | 787,954 | $10.0 million |
| 57 | RAPT THERAPEUTICS INC | COM · 75382E109 | LONG | 389,300 | $9.7 million |
| 58 | REPLIGEN CORP | COM · 759916109 | LONG | 102,698 | $18.5 million |
| 59 | SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 · 803607AD2 | LONG | 50,666,000 | $51.5 million |
| 60 | SPYRE THERAPEUTICS INC | COM NEW · 00773J202 | LONG | 515,000 | $11.1 million |
| 61 | STRUCTURE THERAPEUTICS INC | SPONSORED ADS · 86366E106 | LONG | 280,158 | $11.4 million |
| 62 | TANDEM DIABETES CARE INC | NOTE 1.500% 5/0 · 875372AB0 | LONG | 71,051,000 | $67.2 million |
| 63 | TERNS PHARMACEUTICALS INC | COM · 880881107 | LONG | 2,318,050 | $15.0 million |
| 64 | THERMO FISHER SCIENTIFIC INC | COM · 883556102 | LONG | 75,749 | $40.2 million |
| 65 | THIRD HARMONIC BIO INC | COM · 88427A107 | LONG | 1,316,018 | $14.4 million |
| 66 | TOURMALINE BIO INC | COM · 89157D105 | LONG | 906,820 | $23.7 million |
| 67 | TRANSMEDICS GROUP INC | COM · 89377M109 | LONG | 117,701 | $9.3 million |
| 68 | TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $47.7 million |
| 69 | TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 · 89422GAA5 | LONG | 16,850,000 | $11.1 million |
| 70 | VAXCYTE INC | COM · 92243G108 | LONG | 1,289,965 | $81.0 million |
| 71 | VIRIDIAN THERAPEUTICS INC | COM · 92790C104 | LONG | 323,102 | $7.0 million |
| 72 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 1,647,311 | $75.9 million |